Quantum Computing Is the Market's Next Big Tech — Cheap Stocks

Quantum computing stocks are where AI was five years ago

Last Updated: Dec. 27, 2025 at 5:22 p.m. ET

Tickers: AI

A chip named Willow computed the structure of a molecule 13,000 times faster than the most powerful supercomputer on Earth. The team that built it projects that machines like this could solve problems currently considered impossible within five years. Quantum computing is already being discussed as a transformative technology with direct implications for encryption, drug discovery, optimization of financial portfolios, and national security.

This article puts that development in an investment context for professional traders, institutional investors, and financial analysts looking for low-cost entry points into the quantum theme.

Why investors are comparing quantum to AI

• Clear inflection: AI moved from research labs to commercial products over roughly a five-year period; investors now see a similar commercialization curve for quantum hardware and software.
• Demonstrable speedups: Willow's 13,000x improvement on a molecular-structure calculation is the type of concrete performance gain that can catalyze market adoption.
• Broad addressable markets: potential applications include cryptography, chemicals and materials discovery, logistics and supply-chain optimization, and high-frequency trading strategies.

Quotable takeaway: "Willow's 13,000x speedup signals a practical performance leap that changes which problems are solvable in finance and industry."

What "cheap" means in quantum investing

Cheap is relative. For quantum stocks, cost should be evaluated against:

• Near-term revenue or contract backlog
• R&D intensity and IP defensibility
• Partnerships with hyperscalers, defense agencies, or large pharma
• Clear product roadmaps (qubit roadmap, error mitigation, milestone timeline)

A stock can be cheap on price-to-sales but expensive in cash burn and dilution risk. Conversely, firms with steady non-quantum revenue streams can offer lower-risk exposure to quantum upside.

Practical metrics to watch (for equity selection)

• Qubit count and qubit quality: raw qubit number is insufficient; coherence time, gate fidelity, and error rates matter.
• Quantum volume and benchmark performance: composite measures that capture usable performance.
• Roadmap milestones: dates for error correction, fault-tolerant targets, and commercial SDK releases.
• Revenue mix: percentage of revenue tied to quantum vs. legacy business lines.
• Cash runway and capital raises: months of operational runway at current burn rate.
• Strategic partnerships and government contracts: signal market validation and funded development.

Quotable metric: "Investors should prioritize qubit quality and roadmaps over headline qubit counts when valuing quantum hardware firms."

Investment routes and portfolio construction

• Pure-play quantum hardware/software stocks: highest upside, highest execution risk.
• Diversified technology firms with quantum divisions: lower risk, slower upside capture.
• Thematic ETFs and funds: provide diversified exposure and reduce single-name concentration risk.

Position sizing guidance for professionals: consider small, exploratory allocations (single-digit percentages) within a broader tech/innovation sleeve, increasing exposure only when companies demonstrate repeatable commercial milestones.

Risks and timelines

• Execution risk: scaling from prototype systems (like Willow) to error-corrected, fault-tolerant quantum computers requires breakthroughs in engineering and supply chain.
• Timeline uncertainty: the original research team projects ~5 years for solving currently impossible problems, but commercial adoption may lag due to integration and software ecosystem readiness.
• Security and regulation: quantum's ability to affect encryption creates geopolitical and regulatory uncertainty that could alter market adoption paths.

Quotable risk statement: "The technology leap shown by Willow reduces technical doubt but does not eliminate execution, timeline, or regulatory risks for investors."

Valuation and due diligence checklist for analysts

1. Verify revenue sources and non-quantum cash flows.

2. Model cash runway and dilution scenarios for the next 24–36 months.

3. Assess IP strength and patent positions in hardware and algorithms.

4. Confirm third-party validation: benchmarks, peer-reviewed results, and reproducibility of key claims.

5. Stress-test upside scenarios: mainstream adoption vs. niche use cases.

How to think about the AI ticker (AI) in this theme

The presence of the ticker AI in the discussion reflects market attention on artificial intelligence as a parallel thematic driver. Some AI-focused firms are expanding into quantum research or using quantum-inspired algorithms; others remain purely classical AI plays. Treat ticker exposures as distinct: AI exposure does not equal direct quantum exposure unless the company discloses active quantum programs.

Bottom line for traders and institutional allocators

Quantum computing is transitioning from academic demonstration to demonstrable performance gains—the Willow chip's 13,000x molecular calculation is an inflection signal. For institutional investors and professional traders, the optimal approach is a measured, metrics-driven allocation: prioritize companies with clear commercial paths, durable cash positions, and validated technical milestones. Expect volatility, long timelines for widespread adoption, and pronounced differentiation between winners and losers.

Quotable bottom line: "Willow’s performance is a watershed technical milestone; investors should pursue quantum exposure with a rigorous checklist focused on qubit quality, commercial revenue, and capital durability."

---

Key actions: monitor quarterly milestone disclosures, track quantum-specific performance benchmarks, and reassess allocations as companies convert technical progress into repeatable revenue.